EGFR and cancer: Intervention in the adenosine monophosphate-activated protein kinase (AMPK), mitogen-activated protein kinases (MAPK), and epidermal growth factor receptor (EGFR) signaling pathways, as well as inhibition of the PI3K/Akt pathway through crosstalk effects, are essential for achieving anti-cancer effects.